Cargando…

Sphingolipids modulate the epithelial–mesenchymal transition in cancer

Detalles Bibliográficos
Autores principales:	Levade, T, Andrieu-Abadie, N, Micheau, O, Legembre, P, Ségui, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979435/ https://www.ncbi.nlm.nih.gov/pubmed/27551437 http://dx.doi.org/10.1038/cddiscovery.2015.1

Ejemplares similares

New Insights into the Role of Sphingolipid Metabolism in Melanoma
por: Carrié, Lorry, et al.
Publicado: (2020)

Chemotherapy with ceramide in TNBC
por: Legembre, Patrick, et al.
Publicado: (2015)

Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses
por: Dubot, Patricia, et al.
Publicado: (2020)

Sphingomyelin Synthase 1 (SMS1) Downregulation Is Associated With Sphingolipid Reprogramming and a Worse Prognosis in Melanoma
por: Bilal, Fatima, et al.
Publicado: (2019)

The TNF Paradox in Cancer Progression and Immunotherapy
por: Montfort, Anne, et al.
Publicado: (2019)

Corrigendum: The TNF Paradox in Cancer Progression and Immunotherapy
por: Montfort, Anne, et al.
Publicado: (2019)

The Tricyclodecan-9-yl-xanthogenate D609 Triggers Ceramide Increase and Enhances FasL-Induced Caspase-Dependent and -Independent Cell Death in T Lymphocytes
por: Milhas, Delphine, et al.
Publicado: (2012)

The Epithelial-to-Mesenchymal Transition in Cancer
por: Roche, Joëlle
Publicado: (2018)

Epithelial–mesenchymal transition in cancer
por: Moustakas, Aristidis, et al.
Publicado: (2017)

Mesenchymal-Epithelial Transition in Oral Cancer
por: Patil, Shankargouda, et al.
Publicado: (2015)

Caspase-10-Dependent Cell Death in Fas/CD95 Signalling Is Not Abrogated by Caspase Inhibitor zVAD-fmk
por: Lafont, Elodie, et al.
Publicado: (2010)

Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives
por: Pellerin, Laurence, et al.
Publicado: (2020)

Epithelial–Mesenchymal Transition (EMT)
por: Manfioletti, Guidalberto, et al.
Publicado: (2023)

Anti-TNF, a magic bullet in cancer immunotherapy?
por: Montfort, Anne, et al.
Publicado: (2019)

Exploring the role of sphingolipid machinery during the epithelial to mesenchymal transition program using an integrative approach
por: Meshcheryakova, Anastasia, et al.
Publicado: (2016)

Epithelial–Mesenchymal Transition (EMT) 2021
por: Manfioletti, Guidalberto, et al.
Publicado: (2022)

Revisiting mTOR and Epithelial–Mesenchymal Transition
por: Herrerias, Mariana M., et al.
Publicado: (2020)

Sphingolipids in Inflammation
por: Albi, Elisabetta, et al.
Publicado: (2018)

Lysyl Oxidase at the Crossroads of Mesenchymal Stem Cells and Epithelial-Mesenchymal Transition
por: Thomas, Clémence, et al.
Publicado: (2013)

Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
por: Song, Jaewhan
Publicado: (2020)

Stromal-Modulated Epithelial-to-Mesenchymal Transition in Cancer Cells
por: Atiya, Huda I., et al.
Publicado: (2023)

Sphingolipids: Friends or Foes?
por: Hayashi, Hiroshi
Publicado: (2022)

Can a fibrotic liver afford epithelial-mesenchymal transition?
por: Munker, Stefan, et al.
Publicado: (2017)

TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
por: Bertrand, Florie, et al.
Publicado: (2017)

The Enigma of Sphingolipids in Health and Disease
por: Kleuser, Burkhard
Publicado: (2018)

Hispidulin modulates epithelial-mesenchymal transition in breast cancer cells
por: Kim, Hyun A., et al.
Publicado: (2021)

Sphingolipids in Inflammation: From Bench to Bedside
por: Kitatani, Kazuyuki, et al.
Publicado: (2016)

Epithelial–Mesenchymal Transition: A Major Pathogenic Driver in Idiopathic Pulmonary Fibrosis?
por: Salton, Francesco, et al.
Publicado: (2020)

Diverting epithelial-to-mesenchymal transition to transform cancer cells to adipocytes: A promising strategy to stop metastasis
por: Dalamaga, Maria, et al.
Publicado: (2019)

Mitofusin-2 modulates the epithelial to mesenchymal transition in thyroid cancer progression
por: You, Mi-Hyeon, et al.
Publicado: (2021)

Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition
por: Avila-Carrasco, Lorena, et al.
Publicado: (2019)

RPE epithelial-mesenchymal transition plays a critical role in the pathogenesis of proliferative vitreoretinopathy
por: Li, Xiaohua, et al.
Publicado: (2020)

Potential Role of Sphingolipidoses-Associated Lysosphingolipids in Cancer
por: Dubot, Patricia, et al.
Publicado: (2022)

Downregulation of sphingosine kinase-1 induces protective tumor immunity by promoting M1 macrophage response in melanoma
por: Mrad, Marguerite, et al.
Publicado: (2016)

Epithelial to mesenchymal transition and breast cancer
por: Tomaskovic-Crook, Eva, et al.
Publicado: (2009)

Epithelial-Mesenchymal Transition and Breast Cancer
por: Wu, Yanyuan, et al.
Publicado: (2016)

miR-200c at the nexus of epithelial-mesenchymal transition, resistance to apoptosis, and the breast cancer stem cell phenotype
por: Radisky, Derek C
Publicado: (2011)

Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells
por: Chen, Shuo, et al.
Publicado: (2018)

Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells
por: Chen, Shuo, et al.
Publicado: (2022)

ERK signalling modulates epigenome to drive epithelial to mesenchymal transition
por: Navandar, Mohit, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ofp7n2ph0cu7ulpno0baab4qbq